Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety surveillance of iodixanol in Chinese adults undergoing contrast-enhanced CT
ChiCTR1900024539Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iodixanol, sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of adverse reactions. Started Jun 2019; status: recruiting.
02
Drugs
iodixanol
Beyond the preview
Go deeper on ChiCTR1900024539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024539.